BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21944414)

  • 21. [Diagnosis and treatment of Helicobacter pylori infection. Its relationship with gastrointestinal ulcer and antimicrobial resistance].
    Antelo P; Almuzara M; Avagnina A; Topor J; Barberis C; Barcia T; Araujo G; Vay C; Famiglietti A
    Medicina (B Aires); 2001; 61(5 Pt 1):545-51. PubMed ID: 11721321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.
    Walsh JH; Peterson WL
    N Engl J Med; 1995 Oct; 333(15):984-91. PubMed ID: 7666920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori and the pathogenesis of gastroduodenal disease: Implications for the management of peptic ulcer disease.
    Rotimt O; Nduduba DA; Otegbeye FM
    Niger Postgrad Med J; 2005 Dec; 12(4):289-98. PubMed ID: 16380742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.
    Chan KL; Zhou H; Ng DK; Tam PK
    J Pediatr Surg; 2001 Jul; 36(7):1008-11. PubMed ID: 11431766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits from elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma.
    Graham DY
    Prev Med; 1994 Sep; 23(5):712-6. PubMed ID: 7845945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.
    Hunt RH
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):36S-40S; discussion 40S-43S. PubMed ID: 9127625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyspepsia, peptic ulcer, and H. pylori: a remembrance of things past.
    Vakil N
    Am J Gastroenterol; 2010 Mar; 105(3):572-4. PubMed ID: 20203639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J; Börsch G
    Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori: beyond peptic ulcer disease.
    Wisniewski RM; Peura DA
    Gastroenterologist; 1997 Dec; 5(4):295-305. PubMed ID: 9436005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori.
    Fennerty MB
    Arch Intern Med; 1994 Apr; 154(7):721-7. PubMed ID: 8147675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
    Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [H. pylori infection].
    Asaka M; Kato M
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():303-10. PubMed ID: 11838131
    [No Abstract]   [Full Text] [Related]  

  • 34. [Helicobacter pylori in peptic ulcer and gastric cancer].
    Matsukura N; Onda M; Yamashita K
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Helicobacter pylori and ulcer disease: diagnosis and treatment 1995].
    Kayser S; Fried M
    Praxis (Bern 1994); 1996 Sep; 85(39):1197-200. PubMed ID: 8927903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
    Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
    Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of Helicobacter pylori infection during intensive care stay: related to stress ulcer bleeding incidence?
    van der Voort PH; van der Hulst RW; Zandstra DF; Geraedts AA; van der Ende A; Tytgat GN
    J Crit Care; 2001 Dec; 16(4):182-7. PubMed ID: 11815904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years.
    Nakajima S; Nishiyama Y; Yamaoka M; Yasuoka T; Cho E
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S99-S110. PubMed ID: 20586876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications.
    Manuel D; Cutler A; Goldstein J; Fennerty MB; Brown K
    Aliment Pharmacol Ther; 2007 Jun; 25(12):1423-7. PubMed ID: 17539981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.